-
Signature
-
/s/ Elizabeth Villalobos, Attorney-in-Fact for Lee Klarich
-
Issuer symbol
-
PANW
-
Transactions as of
-
03 Feb 2025
-
Net transactions value
-
-$15,222,600
-
Form type
-
4
-
Filing time
-
04 Feb 2025, 16:30:11 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PANW |
Common Stock |
Options Exercise |
$2,968,548 |
+92,048 |
+25% |
$32.25 |
457,904 |
03 Feb 2025 |
Direct |
|
| transaction |
PANW |
Common Stock |
Sale |
$1,888,455 |
-10,448 |
-2.3% |
$180.75 |
447,456 |
03 Feb 2025 |
Direct |
F1, F2 |
| transaction |
PANW |
Common Stock |
Sale |
$3,978,108 |
-21,906 |
-4.9% |
$181.60 |
425,550 |
03 Feb 2025 |
Direct |
F1, F3 |
| transaction |
PANW |
Common Stock |
Sale |
$6,810,442 |
-37,304 |
-8.8% |
$182.57 |
388,246 |
03 Feb 2025 |
Direct |
F1, F4 |
| transaction |
PANW |
Common Stock |
Sale |
$5,495,731 |
-29,949 |
-7.7% |
$183.50 |
358,297 |
03 Feb 2025 |
Direct |
F1, F5 |
| transaction |
PANW |
Common Stock |
Sale |
$18,412 |
-100 |
-0.03% |
$184.12 |
358,197 |
03 Feb 2025 |
Direct |
F1 |
| holding |
PANW |
Common Stock |
|
|
|
|
|
740,000 |
03 Feb 2025 |
See footnote |
F7 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PANW |
Stock Option (right to buy) |
Options Exercise |
$0 |
-92,048 |
-8.3% |
$0.000000 |
1,012,110 |
03 Feb 2025 |
Common Stock |
92,048 |
$32.25 |
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: